A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Renji Hospital is a comprehensive tertiary hospital with a comprehensive range of disciplines, integrating medical, teaching, and scientific research.
Shanghai, China Clinical Trial Location
Shanghai Jiaotong University School of Medicine, Renji Hospital
145 Shandong Middle Rd, Huangpu,